Overview

Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer

Status:
NOT_YET_RECRUITING

Trial end date:
2027-03-21

Target enrollment:

Participant gender:

Summary

This is an Open, Single-arm, Multicenter, Prospective Phase II Study of Fuquinitinib Combined With Tegafur Gimeracil Oteracil in the Third-line Treatment of Patients With Advanced Metastatic CRC

Phase:

PHASE2

Details

Lead Sponsor:

Guangzhou University of Traditional Chinese Medicine